Market Moves
Science Corp. Raises $230M for Brain-Computer Interface Push
Max Hodak's neurotechnology company secures major Series C funding as the BCI industry consolidates around clinical applications and commercial viability.
Tag: Max Hodak
2 articles
Market Moves
Science Corporation Raises $230 Million for Vision-Restoring Retinal Implant
Max Hodak's Science Corporation secures $230 million to commercialize its retinal BCI implant, marking one of the largest funding rounds in neurotechnology as vision restoration approaches clinical reality.
Stay Ahead of the Curve
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. Unsubscribe anytime. We respect your privacy.